Stock Report Entero Therapeutics Inc. with In-Depth Stock Analysis

Entero Therapeutics Inc. XNAS: ENTO

0.52 -0.02 (-3.70%)

34,631 XNAS Volume

XNAS 28 Mar, 2025 1:57 PM (EDT)

Board Meeting

The board meeting for Entero Therapeutics Inc. is scheduled for today, for the purpose of First Wave BioPharma Inc Annual Report for 2024 See details

Detailed Stock Analysis for Entero Therapeutics Inc. with Real-time Stock Report